Press Coverage

Johnson & Johnson, Mauna Kea launch study of lung cancer biopsy guidance tool

20 September 2021

No longer will surgeons be flying blind while performing biopsies of peripheral lung nodules—at least, not if Mauna Kea Technologies and Johnson & Johnson’s Lung Cancer Initiative have anything to say about it.

Latest News

Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform 

Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform 

Mauna Kea Technologies Announces the Successful Completion of Its Financial Restructuring and €6M Capital Raise 

Mauna Kea Technologies Announces the Successful Completion of Its Financial Restructuring and €6M Capital Raise 

Mauna Kea Technologies Exits Safeguard Proceedings Following Court Approval of its Plan and Initiates Minimum €5M Capital Raise 

Mauna Kea Technologies Exits Safeguard Proceedings Following Court Approval of its Plan and Initiates Minimum €5M Capital Raise 

No results found.